Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma.

Yacoub A YousefAmal M NoureldinIyad SultanRasha DeebajahMaysa Al-HussainiMunir ShawagfehMustafa MehyarMona MohammadImad JaradatIbrahim AlNawaiseh

Published in: Journal of ophthalmology (2020)

Intravitreal melphalan is a promising modality for treatment of vitreous seeds, and the dose of 20-30 μg of melphalan sounds to be safe and effective for refractory and recurrent vitreous seeds.μg of melphalan sounds to be safe and effective for refractory and recurrent vitreous seeds.

Keyphrases

high dose
vascular endothelial growth factor
low dose
diabetic retinopathy
age related macular degeneration
combination therapy
optical coherence tomography